Comparison of two models for predicting non-sentinel lymph node metastases in sentinel lymph node-positive breast cancer patients

被引：10
作者：
D'Eredita G. [1 ]
Troilo V.L. [1 ]
Fischetti F. [1 ]
Rubini G. [2 ]
Berardi T. [1 ]
机构：
[1] Interdepartmental Centre for Breast Cancer, University of Bari, 70125 Bari, Policlinico, Piazza Giulio Cesare
[2] U.O.C. Nuclear Medicine, Department of Internal and Public Medicine, University of Bari, Bari
来源：
Updates in Surgery | 2011年 / 63卷 / 3期
关键词：
Axillary lymph node dissection; Micrometastasis; MSKCC nonogram; Tenon score;
D O I：
10.1007/s13304-011-0079-2
中图分类号：
学科分类号：
摘要：
Several models for the prediction of non-sentinel lymph node (SLN) metastasis in SLN-positive breast cancer patients have been proposed. In this study, the authors evaluate the Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram and an axilla scoring system from Tenon Hospital to predict the probability of having non-(SLN) involvement and to define their actual usefulness when applied to the subgroup of patients with micrometastasis in SLN. The study population consisted of 103 patients: 74 with macrometastasis and 29 with micrometastasis in the SLN. The receiver operating characteristic (ROC) curves were drawn and the area under the curves (AUCs) was calculated to assess the discriminative power of the nomograms. Both the ROCs and relative AUCs were calculated for all the patients in the study and for the two subgroups. The AUC for the entire study population was 0.712 in the MSKCC nomogram and 0.759 in the Tenon score. In 74 patients with macrometastasis in SLN, the AUC was 0.760 in MSKCC nomogram and 0.707 in Tenon score. Micrometastasis in SLN was found in t29 patients: AUC was 0.577 in he MSKCC nomogram and 0.738 in the Tenon score. Several institutions have tested the MSKCC nomogram, with AUC ranging from 0.58 to 0.84. It was not validated by four studies, which did not recommend its use in patients with micrometastasis. In our results, the validation of the Tenon score confirmed its relevance even in patients with micrometastasis in SLN. © 2011 Springer-Verlag.
引用
收藏
页码：163 / 170
页数：7
相关论文
共 49 条
  • [1] Giuliano A.E., Haigh P.I., Brennan M.B., Hansen N.M., Kelley M.C., Ye W., Glass E.C., Turner R.R., Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer, Journal of Clinical Oncology, 18, 13, pp. 2553-2559, (2000)
  • [2] Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., Costa A., De Cicco C., Geraghty J.G., Luini A., Sacchini V., Veronesi P., Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes, Lancet, 349, 9069, pp. 1864-1867, (1997)
  • [3] Bolster M.J., Peer P.G.M., Bult P., Thunnissen F.B.J.M., Schapers R.F.M., Meijer J.W.R., Strobbe L.J.A., Van Berlo C.L.H., Klinkenbijl J.H.G., Beex L.V.A.M., Wobbes T., Tjan-Heijnen V.C.G., Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study, Annals of Surgical Oncology, 14, 1, pp. 181-189, (2007)
  • [4] Zavagno G., De Salvo G.L., Bozza F., Scalco G., Marconato R., Valletta S., Racano C., Burelli P., Nitti D., Lise M., Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer, Breast Cancer Research and Treatment, 86, 2, pp. 171-179, (2004)
  • [5] Nos C., Harding-MacKean C., Freneaux P., Trie A., Falcou M.C., Sastre-Garau X., Clough K.B., Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, British Journal of Surgery, 90, 11, pp. 1354-1360, (2003)
  • [6] Cady B., Case against axillary lymphadenectomy for most patients with infiltrating breast cancer, Journal of Surgical Oncology, 66, 1, pp. 7-10, (1997)
  • [7] Changsri C., Prakash S., Sandweiss L., Bose S., Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery, Breast Journal, 10, 5, pp. 392-397, (2004)
  • [8] Cserni G., Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla, European Journal of Surgical Oncology, 27, 6, pp. 532-538, (2001)
  • [9] Viale G., Maiorano E., Pruneri G., Et al., Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy, Ann Surg, 241, pp. 319-325, (2005)
  • [10] Wada N., Imoto S., Yamauchi C., Hasebe T., Ochiai A., Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node, European Journal of Surgical Oncology, 32, 1, pp. 29-33, (2006)
12345